Thursday 5 October 2017

Antimicrobial Packaging Market Estimated to generate revenues worth USD 11.92 billion by 2024 : Grand View Research,Inc.

The global antimicrobial packaging market is expected to reach USD 11.92 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for confectionery & bakery products is expected to drive the global antimicrobial packaging market. Apart from bakery products, these agents are widely used in meat, poultry, seafood grain seeds, fruits, and vegetables.
Antimicrobial packaging releases active agents into food products which help to inhibit the growth of microorganisms and increase the shelf life. These releasing compounds maintain the food quality and reduce the need for preservatives and additives.
Antimicrobial active packaging is widely used in healthcare applications. These elements are specifically used to protect the plastic products, tablets and medical equipment against bacteria & fungal growth. Antimicrobial preservatives such as ethanol, phenol, cresol, parabens and bronopol can be added to pharmaceutical products to protect against microbial contamination.
However, antimicrobial agents derived from synthetic pathogenic sources are not found to satisfy consumers as they demand products extracted from natural sources. Such a factor is expected to hinder the overall market growth over the next eight years.
Browse full report by Grand View Research:
Further key findings from the report suggest:
·         The global antimicrobial packaging market demand was 6.51 million tons in 2015 and is expected to reach 10.09 million tons by 2024, growing at a CAGR of 5.0% from 2016 to 2024
·         Plastics were the leading base material used for antimicrobial packaging and accounted for 64.8% of total volume in 2015. Biopolymers are expected to witness the highest growth of 6.3% over the forecast period owing to its good physical, mechanical and chemical properties. In addition, they are recognized as an asset to waste processing.
·         Organic acid were the leading antimicrobial agents consumed and accounted for 37.3% of total market volume in 2015. Bacteriocins are expected to witness the highest growth of 5.4% over the forecast period.
·         Pouches emerged as the most dominant pack product and accounted for 39.2% of global volume in 2015. The segment is expected to witness similar trend in the near future due to its usage across different industries. Pouches are also expected to witness the highest growth of 5.5% over the forecast period.
·         Food & beverages were the most dominant application segment and accounted for 44.5% of total market volume in 2015. Stringent regulations regarding food safety across various regional markets have led to the increased penetration in the industry. The segment is also expected to witness the highest growth of 5.3% from 2016 to 2024. Moreover, controlled release packaging technology has been gaining wide importance for food packaging applications due to its impeccable response with respect to time.
·         Asia Pacific was the leading regional market and accounted for 33.3% of global demand in 2015. Busy lifestyle coupled with shifting preferences to consume ready to eat meals particularly in countries such as Japan, India and China has led to growth in the regional market. The region is also expected to witness the highest growth of 6.1% over the forecast period.
·         Key companies operating in the global market include Mondi Plc, BASF SE, Dow Chemicals, Dunmore Corporation, PolyOne Corporation, Linpac Senior Holdings, Bicote Corporation and Microban International. Agion Colorcon, a pharmaceutical company, is using a new antimicrobial product Agion Technologies, in their product line named No-Tox AM.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/food-safety-and-processing
Grand View Research has segmented the global antimicrobial packaging market on the basis of base material, antimicrobial agents, technology, pack type, application and region:
Antimicrobial Packaging Base Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
·         Plastics
·         Biopolymers
·         Paperboard
·         Others
Antimicrobial Packaging Antimicrobial Agents Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
·         Organic Acid
·         Bacteriocins
·         Others
Antimicrobial Packaging Technology Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
·         Active
·         Controlled release
Antimicrobial Packaging Pack Type Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024
·         Carton Packages
·         Pouches
·         Others
Antimicrobial Packaging Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
·         Food & Beverage
·         Healthcare
·         Personal Care
·         Others
Antimicrobial Packaging Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    UK
o    Spain
·         Asia Pacific
o    China
o    India
·         Central & South America
o    Brazil
·         Middle East & Africa

About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com



at No comments:

Anti-snoring devices and snoring surgery market Estimated to generate revenues worth USD 1.84 billion by 2024 : Grand View Research,Inc.



Global anti-snoring devices and snoring surgery market is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market.
The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices. The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. North America and Europe are the major shareholders of this industry due mainly to the increasing awareness associated with available treatment options and the eventual rise in popularity and adoption of these products. The Asia Pacific region is expected to witness high growth as a consequence of the untapped population base characterized with a snoring condition, higher levels of awareness regarding the effects of snoring, and the presence of well-established players in the sector. 
Browse full report by Grand View Research:
Further key findings from the study suggest:
·         North America is estimated to lead the industry with the largest market share in 2015.This growth is attributed to the rapidly increasing popularity and the resultant high market penetration of such treatment devices. Asia Pacific is expected to exhibit the highest growth rate owing to the large untreated population and the rising awareness levels with regard to treatment options and the notorious health consequences associated with this condition.
·         In surgery, somnoplasty is estimated to be the fastest growing segment due largely to factors, such as low cost, reduced surgical trauma, less invasive, and chances of fewer complications in comparison to the traditional surgery procedures
·         The anti-snoring devices and snoring surgery market comprises several local as well as global players. Some key market players include Tomed Dr. Toussaint GmbH, Apnea Sciences Corporation, and Meditas Ltd., among others. The companies have adopted several organic and inorganic strategies in order to gain prominence in this sector. A few of these strategies include geographic expansion, new product launches, new product development, partnerships, collaborations, and mergers and acquisitions, among others. For instance, in March 2015, Meditas Ltd. launched nasal dilators for uninterrupted flow of air. 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global anti-snoring devices and snoring surgery market on the basis of type and region:
Anti-Snoring Devices Type Outlook (Revenue, USD Million, 2013 - 2024)
·         Oral
·         Nasal Dilator
·         Chin Strap
·         Position Control
·         Tongue Stabilizing Devices
·         Expiratory Positive Airway Pressure
Snoring Surgical Procedure Outlook (Revenue, USD Million, 2013 - 2024)
·         Uvulopalatopharyngoplasty
·         Laser-Assisted Uvulopalatoplasty
·         Radiofrequency Ablation
·         Sclerotherapy
·         Pillar Procedure
·         Septoplasty
·         Palatal Stiffening Procedures
·         Other anti-snoring surgical procedures 
Anti-Snoring Devices And Snoring Surgery Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com





at No comments:

Preclinical imaging market Estimated to generate revenues worth USD 3.6 billion by the year 2024 : Grand View Research,Inc.

The global preclinical imaging market is expected to reach around USD 3.6 billion by the year 2024, according to a report performed by Grand View Research, Inc. The swift increase in the number of clinical research organizations (CROs), pharmaceutical companies, and research and development organizations is propelling the demand for preclinical imaging.
Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for Preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are the wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.
North America comprises the U.S. and Canada markets. North America and Europe together accounted for the largest market share in 2015. The increased research and development funding coupled with the presence of a highly developed research infrastructure is accelerating the growth of the market in Europe and North America.
On the other hand, the governing stringent regulatory guidelines are restricting the growth of the market in North America. Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the easy availability of resources, the presence of an advanced research infrastructure, and the allocation of government funds for R&D activities.
Browse full report by Grand View Research:
Further key findings from the study suggest:
·         The optical imaging devices segment captured the largest market share of the overall market in 2015. The largest market share was mainly attributed to the extensive application of these devices in small animal imaging and research projects.
·         The multimodal imaging devices segment is anticipated to show a significant growth rate from 2016 to 2024. The increasing adoption of these devices owing to the integration of multiple imaging modalities into a single unit is the major factor expected to drive the growth of this segment during the forecast period.
·         The reagents segment accounted for a significant market share in 2015 as these products are purchased repeatedly, unlike in the case of imaging devices
·         North America captured the largest market share of around 35% in 2015. The market is expected to maintain its dominance during the forecast period. Well-established research infrastructure, the growing number of research and development activities, and the rising investments in R&D are some of the factors supporting the growth of the market in this region.
·         Asia Pacific is anticipated to show a significant growth rate from 2016 to 2024 owing to the rapidly expanding contract research organization (CRO) industry in this region
·         The exit of the major players from the market is creating growth opportunities for the other smaller, domestic Preclinical imaging system manufacturers
·         The major market players include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics, Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Preclinical imaging device market on the basis of product type and geography.
Preclinical imaging product outlook, 2014 & 2024 (USD Billion)
·         Medical Devices
o    CT Imaging
o    MRI Imaging
o    PET/SPECT Imaging
o    Multimodal Imaging
o    Optical Imaging 
o    Ultrasound Imaging
o    Photoacoustic (PAT) Imaging
·         Reagents
·         Services
Preclinical imaging regional outlook, 2014 & 2024 (USD Billion)
·         North America
o    U.S. Preclinical Imaging Market by Product Type
o    Canada Preclinical Imaging Market by Product Type
·         Europe
o    Germany Preclinical Imaging Market by Product Type
o    France Preclinical Imaging Market by Product Type
·         Asia Pacific
o    China Preclinical Imaging Market by Product Type
o    India Preclinical Imaging Market by Product Type
·         Latin America
o    Brazil Preclinical Imaging Market by Product Type
o    Mexico Preclinical Imaging Market by Product Type
·         MEA
o    South Africa Preclinical Imaging Market by Product Type
About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com


at No comments:
Subscribe to: Posts (Atom)